行情

TTNP

TTNP

Titan制药
NASDAQ

实时行情|Nasdaq Last Sale

0.2120
+0.0239
+12.71%
盘后: 0.2100 -0.002 -0.94% 19:16 12/09 EST
开盘
0.1970
昨收
0.1881
最高
0.2150
最低
0.1900
成交量
1,221.64万
成交额
--
52周最高
2.450
52周最低
0.1420
市值
1,216.43万
市盈率(TTM)
-0.1390
分时
5日
1月
3月
1年
5年

分析师评级

2位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

EPS

TTNP 新闻

  • 5 Safe And Cheap Dividend Stocks To Invest (December 2019)
  • Seeking Alpha - Article.2天前
  • Top Holdings Of Dividend ETFs (Part 2: The Top 7 By Sector In November 2019)
  • Seeking Alpha - Article.2天前
  • Comcast: Undervalued After Recent Pullback
  • Seeking Alpha - Article.3天前
  • Bernie Sanders unveils plan to boost broadband access, break up internet and cable titans
  • CNBC.com.3天前

更多

所属板块

制药
+0.14%
制药与医学研究
+0.23%

热门股票

名称
价格
涨跌幅

TTNP 简况

Titan Pharmaceuticals, Inc. (Titan) is a specialty pharmaceutical company. The Company is engaged in developing therapeutics for the treatment of medical disorders. The Company's segment is engaged in the development of pharmaceutical products. The Company's product development programs utilize its long-term drug delivery platform, ProNeura. The Company's drug candidate, Probuphine, is being developed for the long-term maintenance treatment of opioid dependence. Titan's ProNeura continuous drug delivery system consists of a small, solid rod made from a mixture of ethylene-vinyl acetate (EVA) and a drug substance. The Company focuses on developing two product development programs, the first one with a ropinirole implant for the treatment of Parkinson's disease (PD) and the second one with a Triiodothyronine (T3) implant for the treatment of hypothyroidism.
展开

Webull提供Titan Pharmaceuticals, Inc.的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。